Skip to main content

May 2010 - FRMC

Department

News Connection
05/24/2010
The US Food and Drug Administration (FDA) has approved Natazia, a combination hormonal tablet for use as an oral contraceptive. Natazia contains two female hormones, an estrogen (estradiol valerate) and a progestin (dienogest), and is the...
The US Food and Drug Administration (FDA) has approved Natazia, a combination hormonal tablet for use as an oral contraceptive. Natazia contains two female hormones, an estrogen (estradiol valerate) and a progestin (dienogest), and is the...
The US Food and Drug...
05/24/2010
First Report Managed Care
Conference Insider
05/24/2010
Value-based design insurance programs have remained a viable investment strategy even during the latest economic downturn, according to the results of a recent survey.  
Value-based design insurance programs have remained a viable investment strategy even during the latest economic downturn, according to the results of a recent survey.  
Value-based design insurance...
05/24/2010
First Report Managed Care
News Connection
05/24/2010
In a recent controlled preintervention/postintervention study, researchers found that although Health Resources and Services Administration (HRSA) Health Disparities Collaboratives (HDCs) are known to improve quality of care in community...
In a recent controlled preintervention/postintervention study, researchers found that although Health Resources and Services Administration (HRSA) Health Disparities Collaboratives (HDCs) are known to improve quality of care in community...
In a recent controlled...
05/24/2010
First Report Managed Care
News Connection
05/21/2010
Health insurers are considering the financial impact of mandatory medical loss ratios (MLRs) requiring them to spend minimum percentages of the premiums they collect on providing healthcare to customers.
Health insurers are considering the financial impact of mandatory medical loss ratios (MLRs) requiring them to spend minimum percentages of the premiums they collect on providing healthcare to customers.
Health insurers are considering...
05/21/2010
First Report Managed Care
News Connection
05/21/2010
Temporarily delaying mandated reimbursement cuts for physicians providing Medicare services has become a routine and recurring event in the US Congress. 
Temporarily delaying mandated reimbursement cuts for physicians providing Medicare services has become a routine and recurring event in the US Congress. 
Temporarily delaying mandated...
05/21/2010
First Report Managed Care
Feature
05/24/2010
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat adults with moderate-to-severe rheumatoid arthritis (RA).
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat adults with moderate-to-severe rheumatoid arthritis (RA).
Actemra (tocilizumab) is an...
05/24/2010
First Report Managed Care
Feature
05/24/2010
Bevacizumab and cetuximab, have been singled out as examples of high-cost/low-value medical care. Previously, bevacizumab has been shown to extend median survival time by 3 to 5 months at a cost that can exceed $8000 per month.
Bevacizumab and cetuximab, have been singled out as examples of high-cost/low-value medical care. Previously, bevacizumab has been shown to extend median survival time by 3 to 5 months at a cost that can exceed $8000 per month.
Bevacizumab and cetuximab, have...
05/24/2010
First Report Managed Care